Clinical Trial Update: A Study to Evaluate the Effects of Laropiprant on the Antiplatelet Effects of Clopidogrel and Aspirin in Combination (MK-0524A-114)(COMPLETED) [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluated whether laropiprant influences the antiplatelet effects of clopidogrel and aspirin in patients with primary hypercholesterolemia or…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia
• Mixed Hyperlipidemia

Drugs mentioned

• Aspirin (Aspirin)
• CLOPIDOGREL (CLOPIDOGREL)
• Laropiprant (laropiprant)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Primary Hypercholesterolemia, Mixed Hyperlipidemia | Phase 1 | Status: COMPLETED | Results posted: 2011-04-18